§2297e–4. AVLIS Commercialization Fund within United States Enrichment Corporation
(a) Establishment
The Corporation may establish within the Corporation an AVLIS Commercialization Fund, which shall consist of not more than $364,000,000 paid into the Fund by the Corporation from amounts provided in appropriation Acts for such purposes and from the retained earnings of the Corporation.
(b) Expenditures from Fund
Amounts in the AVLIS Commercialization Fund shall be available for-
(1) expenses of the Corporation in preparing the assessment under section 2297e of this title;
(2) expenses of predeployment activities under section 2297e–2 of this title; and
(3) grants to the private corporation under section 2297e–3 of this title.
(c) Limitations
(1) Exclusive source of funds
The Corporation may not incur any obligation, or expend any amount, with respect to AVLIS or alternative technologies for uranium enrichment, except from amounts available in the AVLIS Commercialization Fund.
(2) Unavailable for construction costs
No amount may be used from the AVLIS Commercialization Fund for the costs of constructing an AVLIS, or alternative technologies for uranium enrichment, production facility or engaging in directly related preconstruction activities (other than activities specified in subsection (b) of this section).
(d) Authorization of appropriations
There is authorized to be appropriated $364,000,000 from the Uranium Enrichment Special Fund for purposes of this section.
(e) Cost report
On the basis of the assessment under section 2297e(a)(3) of this title, the Corporation shall submit to the Congress a report on the capital requirements for commercialization of AVLIS.
(Aug. 1, 1946, ch. 724, title II, §1605, as added Oct. 24, 1992,